These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 26633836)
1. Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study. Franchi F; Rollini F; Cho JR; King R; Phoenix F; Bhatti M; DeGroat C; Tello-Montoliu A; Zenni MM; Guzman LA; Bass TA; Ajjan RA; Angiolillo DJ Thromb Haemost; 2016 Mar; 115(3):622-31. PubMed ID: 26633836 [TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study. Rollini F; Franchi F; Cho JR; Degroat C; Bhatti M; Ferrante E; Patel R; Darlington A; Tello-Montoliu A; Desai B; Ferreiro J; Muniz-Lozano A; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ J Cardiovasc Transl Res; 2014 Feb; 7(1):53-63. PubMed ID: 24395495 [TBL] [Abstract][Full Text] [Related]
3. Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study. Franchi F; Rollini F; Garcia E; Rivas Rios J; Rivas A; Agarwal M; Kureti M; Nagaraju D; Wali M; Briceno M; Moon JY; Kairouz V; Yaranov D; Been L; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ Thromb Haemost; 2020 Jan; 120(1):83-93. PubMed ID: 31470444 [TBL] [Abstract][Full Text] [Related]
4. Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Ueno M; Ferreiro JL; Tomasello SD; Tello-Montoliu A; Capodanno D; Seecheran N; Kodali M; Dharmashankar K; Desai B; Charlton RK; Bass TA; Angiolillo DJ JACC Cardiovasc Interv; 2011 Aug; 4(8):905-12. PubMed ID: 21851906 [TBL] [Abstract][Full Text] [Related]
5. Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes. Lu D; Owens J; Kreutz RP Thromb Res; 2013 Aug; 132(2):e94-8. PubMed ID: 23920429 [TBL] [Abstract][Full Text] [Related]
6. Response to antiplatelet therapy is independent of endogenous thrombin generation potential. Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170 [TBL] [Abstract][Full Text] [Related]
7. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. Gurbel PA; Bliden KP; Logan DK; Kereiakes DJ; Lasseter KC; White A; Angiolillo DJ; Nolin TD; Maa JF; Bailey WL; Jakubowski JA; Ojeh CK; Jeong YH; Tantry US; Baker BA J Am Coll Cardiol; 2013 Aug; 62(6):505-12. PubMed ID: 23602770 [TBL] [Abstract][Full Text] [Related]
8. Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy. Angiolillo DJ; Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Sumner S; Desai B; Charlton RK; Box LC; Zenni M; Guzman LA; Bass TA Thromb Haemost; 2011 Aug; 106(2):253-62. PubMed ID: 21614414 [TBL] [Abstract][Full Text] [Related]
9. Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease? Khanna V; Mikael R; Thayalasamy K; Sambu N; Dimitrov BD; Englyst N; Calver AL; Corbett S; Gray H; Simpson IA; Wilkinson JR; Curzen N J Thromb Haemost; 2015 Jun; 13(6):920-30. PubMed ID: 25809653 [TBL] [Abstract][Full Text] [Related]
10. The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients. Gurbel PA; Bliden KP; Antonino MJ; Stephens G; Gretler DD; Jurek MM; Pakyz RE; Shuldiner AR; Conley PB; Tantry US J Thromb Haemost; 2010 Jan; 8(1):43-53. PubMed ID: 19817997 [TBL] [Abstract][Full Text] [Related]
11. Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel. Kreutz RP; Owens J; Lu D; Nystrom P; Jin Y; Kreutz Y; Desta Z; Flockhart DA Platelets; 2015; 26(4):358-63. PubMed ID: 24833046 [TBL] [Abstract][Full Text] [Related]
12. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study. Park Y; Jeong YH; Tantry US; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA Thromb Haemost; 2014 Dec; 112(6):1198-208. PubMed ID: 25182660 [TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study. Ueno M; Ferreiro JL; Desai B; Tomasello SD; Tello-Montoliu A; Capodanno D; Capranzano P; Kodali M; Dharmashankar K; Charlton RK; Bass TA; Angiolillo DJ JACC Cardiovasc Interv; 2012 Mar; 5(3):293-300. PubMed ID: 22440495 [TBL] [Abstract][Full Text] [Related]
14. High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study. Zhao X; Li Q; Tu C; Zeng Y; Ye Y Cardiovasc Diabetol; 2020 Oct; 19(1):171. PubMed ID: 33036613 [TBL] [Abstract][Full Text] [Related]
15. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330 [TBL] [Abstract][Full Text] [Related]
16. Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting. Gurbel PA; Bliden KP; Guyer K; Aggarwal N; Tantry US Thromb Res; 2007; 119(5):563-70. PubMed ID: 16806409 [TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease. Galli M; Franchi F; Rollini F; Been L; Jaoude PA; Rivas A; Zhou X; Jia S; Maaliki N; Lee CH; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Geisler T; Jennings LK; Bass TA; Angiolillo DJ Thromb Haemost; 2022 Aug; 122(8):1341-1351. PubMed ID: 34983074 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Three Tests to Distinguish Platelet Reactivity in Patients with Renal Impairment during Dual Antiplatelet Therapy. Guo LZ; Kim MH; Kim TH; Park JS; Jin E; Shim CH; Choi SY; Serebruany VL Nephron; 2016; 132(3):191-7. PubMed ID: 26914786 [TBL] [Abstract][Full Text] [Related]
19. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report. Chyrchel B; Totoń-Żurańska J; Kruszelnicka O; Chyrchel M; Mielecki W; Kołton-Wróż M; Wołkow P; Surdacki A Platelets; 2015; 26(6):593-7. PubMed ID: 25350775 [TBL] [Abstract][Full Text] [Related]
20. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]